Prevention is better than cure for killer cardiovascular disease

In CategoryCardiovascular Health
ByRuss Bianchi

“A pinch of prevention is worth more than a pound of cure.” Benjamin Franklin, POOR RICHARD’S ALMANAC

So what is causing a pandemic in cardiovascular diseases in North America when we are smoking 80% less than 4 decades ago?!

It’s The High Fructose Corn Syrup, STUPID*!

HFCS is flooding all aspects of cosmetics, food, beverages, drugs, flavors, colors, etc. (HFCS did not exist in 1971) and is the primary and major cause for cardiovascular disease!

HFCS jacks up triglycerides, high LDL counts, increased blood glucose and insulin instability, depression, inflammatory symptoms, liver disease, renal failure, blindness, heart attacks, thyroid lethargy, cancers, weight gain and obesity, PLUS (note sarcasm) for added bonus * STUPIDITY!

Yes, that is correct, the consumption of as little as one HFCS sweetened soda per week can and will LOWER your IQ by over 50 points, in 6 months or less, as PROVEN by a major published, vetted, medical journal study at UCLA, very recently!

So since CONGRESS (US House & US Senate), their bureaucracies allegedly regulating but actually only codifying premature disease and death (USDA and FDA), The White House, which are all collectively known as ‘UNCLE SAM’, have allowed HFCS to harm you and your families since 1971, is it not only FAIR to return the favor, and vote every singe incumbent, irrespective of political affiliation, who are all guilty of eugenics and genocide on their own constituents, all American citizenry, OUT OF OFFICE this November?!

It seems the reasonable thing to do, at least to me.

DRINK LIFE IN!®

~ Uncle Russ

European experts in cardiovascular medicine will today gather at a two day symposium to address the national agenda on cardiovascular disease prevention, held at Imperial College London and sponsored by leading independent academic and professional publisher SAGE.

Prevention is better than cure for killer cardiovascular disease

Share

Weight-loss pharmaceutical that caused tumors in animal studies approved for Lazy America and FDA approves lorcaserin for weight loss; is wave of heart valve damage imminent?

In CategoryCancer, Drugs and Drug Companies, Government, Weight Health
ByRuss Bianchi

Drugs KILL, Plants CURE!

Got The SAFE Zija® Weight Loss System™, for PERMANENT weight loss, at little or NO COST (FREE under The Team 250® Referral Program)?!

(Note Extreme Sarcasm) – Hmmmm… cancer and heart disease, the cadaver will look great at the premature funeral viewing!

Drink Life In!®

~ Uncle Russ

Perhaps the only thing worse than a population not motivated to cut the size of its collective waistline is approving a “weight-loss” medication that may cause cancer.

Weight-loss pharmaceutical that caused tumors in animal studies approved for Lazy America

and

On June 27, 2012 the U.S. Food and Drug Administration (FDA) approved lorcaserin hydrochloride, a weight-loss pill, for sale in the United States. A pharmaceutical drug allegedly designed to curb appetite signals to brain receptors in the hypothalamus that promote satiety. Rejected in 2010 for causing tumors in tested animals, lorcaserin hydrochloride also claims side-effects ranging from memory lapse to depression.

FDA approves lorcaserin for weight loss; is wave of heart valve damage imminent?

Share

Antibodies Reverse Type 1 Diabetes in New Immunotherapy Animal Study

In CategoryBlood Glucose Conditions
ByRuss Bianchi

GOT ZIJA?!®

Zija® support wellness, and correct antibody and immunity functions, of the body.

Give the body what it requires, and it is the body that corrects!

Drugs KILL, Plants CURE!

Drink Life In!®

~ Uncle Russ

ScienceDaily (July 6, 2012) — Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease. Moreover, just two injections maintained disease remission indefinitely without harming the immune system.

Antibodies Reverse Type 1 Diabetes in New Immunotherapy Animal Study

Share